Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Total Stockholders Equity : ¥6,045.5 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Wuhan Easy Diagnosis Biomedicine Co Total Stockholders Equity?

Wuhan Easy Diagnosis Biomedicine Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥6,045.5 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Wuhan Easy Diagnosis Biomedicine Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥26.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.00.

Wuhan Easy Diagnosis Biomedicine Co Total Stockholders Equity Historical Data

The historical data trend for Wuhan Easy Diagnosis Biomedicine Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Easy Diagnosis Biomedicine Co Total Stockholders Equity Chart

Wuhan Easy Diagnosis Biomedicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

609.71

1,101.79

2,788.83

6,500.01

6,025.89

Wuhan Easy Diagnosis Biomedicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															6,586.51	6,046.18	6,081.07	6,025.89	6,045.50

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Wuhan Easy Diagnosis Biomedicine Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6045.503	-	0)	/	232.521
	=	26.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Wuhan Easy Diagnosis Biomedicine Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(11.156	+	17.807)	/	6045.503
	=	0.00

Wuhan Easy Diagnosis Biomedicine Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Wuhan Easy Diagnosis Biomedicine Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wuhan Easy Diagnosis Biomedicine Co Ltd (SZSE:002932) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Dongxin Road, 2 Floor, Building E, International Students Pioneer Park, Guandong Science and Technology Park, Donghu Development Zone, Hubei, Wuhan, CHN, 430075

Website

http://www.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co Ltd is engaged in the research and development, production and sales of in vitro diagnostic reagents and supporting instruments and mobile ECG products. The company's product profile consists of Molecular diagnosis, Chemiluminescence, Blood gas analysis, and others. It also provides various other solutions such as Mingde Biomolecular Diagnostic Service Solution, Mingde Biothoracic Center Solution, POCT Solution, Remote ECG network construction solution, and others.

Executives

Wang Rui	Directors, executives
Wang Jian Fei	Director

Wuhan Easy Diagnosis Biomedicine Co (SZSE:002932) Headlines

No Headlines